Biotest AG
Records under this name other than the patents Biotest AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,512,226 | Agent for treating disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,550,831 | Method for treating psoriasis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,995,733 | Agents for treating disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,618,805 | Gamma-Sterilisable Nutrient Medium Based on Casein Soya Peptone Agar Formerly held Term ended Term ended Jan 28, 2026 · High confidence | Term ended | Term ended Jan 28, 2026 | High confidence |
| US 9,758,581 | Humanized anti-CD4 antibody with immunosuppressive properties Formerly held Lapsed on the fee record Ended Sep 12, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 12, 2025 | From the USPTO record |
| US 8,586,715 | Humanized anti-CD4 antibody with immunosuppressive properties Formerly held Term ended Term ended Aug 9, 2024 · From the USPTO record | Term ended | Term ended Aug 9, 2024 | From the USPTO record |
| US 8,440,806 | Humanized anti-CD4 antibody with immunosuppressive properties Formerly held Term ended Term ended Jul 8, 2024 · From the USPTO record | Term ended | Term ended Jul 8, 2024 | From the USPTO record |
| US 9,289,509 | Uses of immunoconjugates targeting CD138 Lapsed on the fee record Ended Mar 22, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2024 | From the USPTO record |
| US 7,452,981 | Humanized anti-CD4 antibody with immunosuppressive properties Formerly held Term ended Term ended Mar 19, 2024 · From the USPTO record | Term ended | Term ended Mar 19, 2024 | From the USPTO record |
| US 8,673,304 | Humanized anti-CD4 antibody with immunosuppressive properties Formerly held Term ended Term ended Mar 19, 2024 · From the USPTO record | Term ended | Term ended Mar 19, 2024 | From the USPTO record |